editorial | Q871232 |
scholarly article | Q13442814 |
P50 | author | Nazareno Paolocci | Q42067397 |
P2093 | author name string | David A Wink | |
P2860 | cites work | Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion | Q28361019 |
Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. | Q33943302 | ||
Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling | Q34586280 | ||
Positive inotropic and lusitropic effects of HNO/NO − in failing hearts: Independence from β-adrenergic signaling | Q34983537 | ||
Differential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta | Q35041842 | ||
Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm. | Q35175535 | ||
A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system | Q35234291 | ||
Coordination chemistry of the HNO ligand with hemes and synthetic coordination complexes | Q35983739 | ||
Explaining the phenomenon of nitrate tolerance | Q36272905 | ||
The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO | Q36408421 | ||
Xerogel optical sensor films for quantitative detection of nitroxyl | Q36580222 | ||
Generation of nitroxyl by heme protein-mediated peroxidation of hydroxylamine but not N-hydroxy-L-arginine | Q36926046 | ||
Examining nitroxyl in biological systems | Q37142384 | ||
Identification of nitroxyl-induced modifications in human platelet proteins using a novel mass spectrometric detection method | Q37210656 | ||
A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries. | Q37255292 | ||
Further evidence for distinct reactive intermediates from nitroxyl and peroxynitrite: effects of buffer composition on the chemistry of Angeli's salt and synthetic peroxynitrite | Q40726814 | ||
The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO. | Q41058544 | ||
Reactive oxygen species and the control of vascular function | Q43157291 | ||
Nitric oxide (NO)-induced activation of large conductance Ca2+-dependent K+ channels (BK(Ca)) in smooth muscle cells isolated from the rat mesenteric artery. | Q43184397 | ||
Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning. | Q44260202 | ||
NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries | Q44438485 | ||
Xanthine oxidase converts nitric oxide to nitroxyl that inactivates the enzyme. | Q44758055 | ||
Nitroxyl triggers Ca2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors | Q45149127 | ||
Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure | Q45182847 | ||
The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor | Q45199440 | ||
Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry. | Q45946745 | ||
Redox variants of NO (NO⋅ and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms | Q46104588 | ||
Comparison of the NO and HNO donating properties of diazeniumdiolates: primary amine adducts release HNO in Vivo | Q46860343 | ||
NO+, NO, and NO- donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. | Q51605840 | ||
Phospholamban thiols play a central role in activation of the cardiac muscle sarcoplasmic reticulum calcium pump by nitroxyl. | Q52695418 | ||
Discriminating formation of HNO from other reactive nitrogen oxide species | Q60133388 | ||
Nitric oxide (NO), the only nitrogen monoxide redox form capable of activating soluble guanylyl cyclase | Q71209999 | ||
Bioassay discrimination between nitric oxide (NO.) and nitroxyl (NO-) using L-cysteine | Q72488285 | ||
Arginine conversion to nitroxide by tetrahydrobiopterin-free neuronal nitric-oxide synthase. Implications for mechanism | Q74182276 | ||
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation | Q79243073 | ||
Peroxynitrite and myocardial contractility: in vivo versus in vitro effects | Q79257464 | ||
The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature | Q79451723 | ||
Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae | Q79798643 | ||
Nitroxyl increases force development in rat cardiac muscle | Q79855253 | ||
Mechanism of aerobic decomposition of Angeli's salt (sodium trioxodinitrate) at physiological pH | Q81254793 | ||
Effect of nitroxyl on human platelets function | Q81438726 | ||
P433 | issue | 5 | |
P304 | page(s) | H1217-20 | |
P577 | publication date | 2009-03-13 | |
P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
P1476 | title | The shy Angeli and his elusive creature: the HNO route to vasodilation | |
P478 | volume | 296 |
Q38613516 | Angeli's Salt, a nitroxyl anion donor, reverses endothelin-1 mediated vascular dysfunction in murine aorta |
Q41903293 | Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses |
Q37438138 | Enzymatic generation of the NO/HNO-releasing IPA/NO anion at controlled rates in physiological media using β-galactosidase |
Q38134537 | Italian chemists' contributions to named reactions in organic synthesis: an historical perspective. |
Q38224809 | Nitroxyl (HNO) for treatment of acute heart failure |
Q33946688 | Nitroxyl (HNO): A novel approach for the acute treatment of heart failure |
Q34756677 | The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems. |
Search more.